SLC2A1 and Parkinson disease: The results indicated that HQD improved PD symptoms through the aerobic glycolysis pathway instead of the ketone body pathway, and the activation of the aerobic glycolysis pathway was realized by upregulating the expression of glucose transporter GLUT1 and the content of tricarboxylic acid cycle rate-limiting enzyme CS and the level of HK.